NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 07, 2025 ...

Q2 2025 Management View Nicole A. Kivisto, President and CEO, reported income from continuing operations of $14.1 million or $0.07 per diluted share for the quarter and noted, “Unfavorable weather at ...

Q4 2025 Management View Jennifer A. Parmentier, CEO, reported, "The Win Strategy and our culture of high performance delivered another record year. We had a 17% reduction in recordable incident rate, ...

Discover how US Foods achieved record Q2 2025 performance with $10.1B in sales, market share gains, and raised EBITDA guidance.

For the current quarter ending in September, Microchip Tech expects its per-share earnings to range from 34 cents to 37 cents. The company said it expects revenue in the range of $1.11 billion to ...

Approximately $1.1 billion deployed during Q2 2025, including the acquisition of Care REIT and entry into the UK care home market. Post-Acquisition Investments-- Nearly $220 million of investments ...

Optimum parent company Altice U.S. reported a smaller broadband subscriber decline in the second quarter (Q2) of 2025, a sign ...

SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Doximity Inc. (DOCS) on Thursday reported fiscal first-quarter net income of $53.3 million. The San Francisco-based company said it had profit of 27 cents per ...

Celsius posts 83.9% YoY revenue growth after Alani Nu acquisition, capturing 17.3% of the U.S. energy market. Read the latest ...

Despite the global uncertainty, the RBI on Wednesday retained its annual and quarterly real GDP growth forecasts for 2025-26 ...

TX45 PH-ILD Phase 2 clinical trial is planned to initiate in 2026 to evaluate TX45’s safety and hemodynamic effects in subjects with Pulmonary Hypertension associated with Interstitial Lung Disease ...